Skip to main content
. 2003 Jun;55(6):609–615. doi: 10.1046/j.1365-2125.2003.01813.x

Table 1.

Demographic data pre run-in.

Gender Age (years) FEV1%predicted FEF25-75%predicted ICS ICS daily dose Other asthma treatment
F 40 92 59 BDP 1000 None
F 65 69 42 BDP 800 None
F 25 92 63 BDP 400 Montelukast
M 54 84 68 BDP 800 None
F 46 104 77 BDP 800 None
M 36 85 54 FP 400 Salmeterol
M 25 71 39 BDP 800 None
F 17 95 85 BDP 800 None
M 43 61 32 FP 1000 None
M 26 98 72 BDP 400 None
F 47 68 25 BDP 500 Salmeterol
F 65 86 44 BDP 1200 None
M 45 58 28 BDP 400 None
M 35 60 28 BDP 600 None
M 58 73 45 BUD 800 None
F 42 93 72 BUD 400 None
M 22 74 41 BDP 400 None
F 32 82 56 BDP 400 None
F 45 104 72 FP 1000 None
F 44 73 46 BUD 800 None
9 M, 11 F 41(3) 81(3) 52(4) 685(58)

ICS, inhaled corticosteroid; BDP, beclomethasone dipropionate; FP, fluticasone propionate; BUD, budesonide. Summary statistics are shown as mean (SE).